IL110510A - Pharmaceutical preparations containing glucosidase and / or amylase inhibitor and lipase inhibitor - Google Patents

Pharmaceutical preparations containing glucosidase and / or amylase inhibitor and lipase inhibitor

Info

Publication number
IL110510A
IL110510A IL11051094A IL11051094A IL110510A IL 110510 A IL110510 A IL 110510A IL 11051094 A IL11051094 A IL 11051094A IL 11051094 A IL11051094 A IL 11051094A IL 110510 A IL110510 A IL 110510A
Authority
IL
Israel
Prior art keywords
inhibitor
glucosidase
acarbose
lipase
amylase
Prior art date
Application number
IL11051094A
Other languages
English (en)
Hebrew (he)
Other versions
IL110510A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL110510A0 publication Critical patent/IL110510A0/xx
Publication of IL110510A publication Critical patent/IL110510A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL11051094A 1993-08-05 1994-07-29 Pharmaceutical preparations containing glucosidase and / or amylase inhibitor and lipase inhibitor IL110510A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH233993 1993-08-05

Publications (2)

Publication Number Publication Date
IL110510A0 IL110510A0 (en) 1994-11-11
IL110510A true IL110510A (en) 1999-03-12

Family

ID=4231504

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11051094A IL110510A (en) 1993-08-05 1994-07-29 Pharmaceutical preparations containing glucosidase and / or amylase inhibitor and lipase inhibitor

Country Status (24)

Country Link
US (1) US5643874A (zh)
EP (1) EP0638317B1 (zh)
JP (1) JP2780932B2 (zh)
KR (1) KR100342285B1 (zh)
CN (1) CN1076196C (zh)
AT (1) ATE190503T1 (zh)
AU (1) AU684793B2 (zh)
BR (1) BR9403170A (zh)
CA (1) CA2128044C (zh)
CZ (1) CZ286202B6 (zh)
DE (1) DE59409200D1 (zh)
DK (1) DK0638317T3 (zh)
ES (1) ES2144019T3 (zh)
GR (1) GR3033643T3 (zh)
HU (1) HU222346B1 (zh)
IL (1) IL110510A (zh)
NO (1) NO313490B1 (zh)
NZ (1) NZ264142A (zh)
PL (1) PL175997B1 (zh)
PT (1) PT638317E (zh)
RU (1) RU2141844C1 (zh)
SA (1) SA94150156B1 (zh)
TW (1) TW381025B (zh)
ZA (1) ZA945673B (zh)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001509173A (ja) * 1997-02-05 2001-07-10 エフ・ホフマン−ラ ロシュ アーゲー 胃腸リパーゼ阻害剤の使用
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
GB9727131D0 (en) 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
DE19802700A1 (de) * 1998-01-24 1999-07-29 Bayer Ag Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält
EP1105122B1 (en) * 1998-08-14 2005-04-27 F.Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors
NZ510311A (en) * 1998-09-08 2003-08-29 Smithkline Beecham Corp Lipstatin derivative - soluble fiber tablets
WO2000043036A2 (en) * 1999-01-22 2000-07-27 Hunza Di Maria Carmela Marazzita S.A.S. Lipoprotein complexes and compositions containing them
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
US6235305B1 (en) * 1999-10-29 2001-05-22 2Pro Chemical Essentially nonabsorbable lipase inhibitor derivatives, pharmaceutical compositions and methods of use therefor
US6342519B2 (en) * 1999-10-29 2002-01-29 2 Pro Chemical Oxetanone derivatives
IL144045A0 (en) * 1999-10-29 2002-04-21 Mullins John Jason Gentry Oxetanone derivatives
US6348492B1 (en) * 1999-10-29 2002-02-19 2Pro Chemical Oxetanone derivatives
KR100349334B1 (ko) * 1999-12-08 2002-08-21 박관화 아카비오신 글루코실 시몬진 및 그것의 제조방법.
US7713546B1 (en) 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
PT1307264E (pt) * 2000-07-28 2005-02-28 Hoffmann La Roche Nova composicao farmaceutica
DK1307263T3 (da) * 2000-07-28 2005-08-22 Hoffmann La Roche Hidtil ukendt anvendelse af lipaseinhibitorer
US6849609B2 (en) * 2001-04-10 2005-02-01 James U. Morrison Method and composition for controlled release acarbose formulations
AU2002362061A1 (en) 2001-12-04 2003-06-17 Biogal Gyogyszergyar Rt Preparation of orlistat and orlistat crystalline forms
US7108869B2 (en) * 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US20060185357A1 (en) * 2004-05-07 2006-08-24 Kovacevich Ian D Independently drawing and tensioning lines with bi-directional rotary device having two spools
EP1744772B1 (en) 2004-05-10 2017-08-16 University of Copenhagen Flaxseeds for body weight management
US20060029567A1 (en) * 2004-08-04 2006-02-09 Bki Holding Corporation Material for odor control
ATE439347T1 (de) * 2004-11-23 2009-08-15 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
US8283312B2 (en) * 2005-02-04 2012-10-09 The Research Foundation Of State University Of New York Compositions and methods for modulating body weight and treating obesity-related disorders
US20060229261A1 (en) * 2005-04-12 2006-10-12 John Devane Acarbose methods and formulations for treating chronic constipation
US20070009615A1 (en) * 2005-04-29 2007-01-11 Litao Zhong Compositions and methods for controlling glucose uptake
JP5044398B2 (ja) * 2005-06-09 2012-10-10 武田薬品工業株式会社 固形製剤
JP2009503050A (ja) * 2005-08-04 2009-01-29 ファイザー・リミテッド ピペリジノイル−ピロリジンおよびピペリジノイル−ピペリジン化合物
CN100349614C (zh) * 2005-10-21 2007-11-21 南京工业大学 一种含α－淀粉酶抑制剂的固体混合物及其制备工艺和在制药中的应用
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2007096763A2 (en) * 2006-02-23 2007-08-30 Pfizer Limited Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
TW200831497A (en) * 2006-10-12 2008-08-01 Epix Delaware Inc Carboxamide compounds and their use
AU2007320906A1 (en) 2006-11-13 2008-05-22 Pfizer Products Inc. Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
EP2099755A2 (en) * 2006-11-20 2009-09-16 Glenmark Pharmaceuticals S.A. Acetylene derivatives as stearoyl coa desaturase inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
EP2002825B1 (en) * 2007-06-14 2013-05-22 Krka Pharmaceutical compositions comprising orlistat
WO2009033483A1 (en) 2007-09-12 2009-03-19 Københavns Universitet Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat energy satiety
WO2009037542A2 (en) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Spirocyclic compounds as stearoyl coa desaturase inhibitors
EP2219614A1 (en) * 2007-10-15 2010-08-25 Inventis DDS Pvt Limited Pharmaceutical composition of orlistat
US8569282B2 (en) 2007-12-11 2013-10-29 Cytopathfinder, Inc. Carboxamide compounds and their use
DK2326638T5 (da) * 2008-08-06 2014-01-13 Pfizer Ltd Diazepin- og diazocan-forbindelser som mc4-agonister
JP5752359B2 (ja) * 2010-02-25 2015-07-22 富士フイルム株式会社 体重増加抑制組成物及びこれを含む食品
CA2799708A1 (en) 2010-05-21 2011-11-24 Pfizer Inc. 2-phenyl benzoylamides
TR201100148A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Stabil akarboz förmülasyonları.
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
CN102805744A (zh) * 2011-06-02 2012-12-05 鲁南制药集团股份有限公司 一种治疗或预防肥胖症以及代谢综合症的药物组合物
CN102872062A (zh) * 2011-07-13 2013-01-16 鲁南制药集团股份有限公司 一种治疗或预防肥胖症以及代谢综合症的药物组合物
US8252312B1 (en) * 2011-12-27 2012-08-28 David Wong Oral solid composition comprising a lipid absorption inhibitor
MY188344A (en) 2012-03-09 2021-12-01 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
CN104812737A (zh) * 2012-05-08 2015-07-29 塞利克斯比奥私人有限公司 用于治疗高血糖症的组合物和方法
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
FR3017536B1 (fr) 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
KR101937069B1 (ko) * 2014-12-17 2019-04-03 엠프로스 파마 악티에볼라그 비만 및 관련 대사 장애의 치료를 위한 오를리스타트 및 아카르보스의 변형 방출형 조성물
KR101903150B1 (ko) 2016-09-12 2018-10-01 가톨릭대학교산학협력단 퀴니자린을 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
CN107308154A (zh) * 2017-07-19 2017-11-03 重庆植恩药业有限公司 治疗或预防肥胖症以及代谢综合征的药物组合物及其应用
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
JPS5953920B2 (ja) * 1977-12-28 1984-12-27 東洋醸造株式会社 新規なアミノ糖化合物およびその製法
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS56128774A (en) * 1980-03-14 1981-10-08 Microbial Chem Res Found New physiologically active substance ebelactone and its preparation
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
DK520784A (da) * 1984-01-21 1985-07-22 Hoechst Ag Cycliske polypeptider, deres fremstilling og anvendelse
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
DE68905424T2 (de) * 1988-08-22 1993-06-24 Takeda Chemical Industries Ltd Alpha-glucosidaseinhibitor zur foerderung der calciumabsorption.
DK244090D0 (da) * 1990-10-09 1990-10-09 Novo Nordisk As Kemiske forbindelser
US5240962A (en) * 1991-04-15 1993-08-31 Takasago Institute For Interdisciplinary Science, Inc. Antiobesity and fat-reducing agents
GB9122051D0 (en) * 1991-10-17 1991-11-27 Univ Nottingham Medicines

Also Published As

Publication number Publication date
AU684793B2 (en) 1998-01-08
NO942900L (no) 1995-02-06
ES2144019T3 (es) 2000-06-01
PT638317E (pt) 2000-07-31
GR3033643T3 (en) 2000-10-31
RU2141844C1 (ru) 1999-11-27
DE59409200D1 (de) 2000-04-20
EP0638317A1 (de) 1995-02-15
JP2780932B2 (ja) 1998-07-30
EP0638317B1 (de) 2000-03-15
PL175997B1 (pl) 1999-03-31
CN1106701A (zh) 1995-08-16
HUT68300A (en) 1995-06-28
BR9403170A (pt) 1995-04-18
ZA945673B (en) 1995-02-07
HU222346B1 (hu) 2003-06-28
US5643874A (en) 1997-07-01
CZ286202B6 (cs) 2000-02-16
CA2128044A1 (en) 1995-02-06
NO313490B1 (no) 2002-10-14
HU9402249D0 (en) 1994-09-28
DK0638317T3 (da) 2000-06-26
CA2128044C (en) 2007-02-20
IL110510A0 (en) 1994-11-11
AU6883994A (en) 1995-02-16
NO942900D0 (zh) 1994-08-04
KR950005319A (ko) 1995-03-20
KR100342285B1 (ko) 2002-10-25
JPH0753409A (ja) 1995-02-28
PL304557A1 (en) 1995-02-06
CN1076196C (zh) 2001-12-19
TW381025B (en) 2000-02-01
ATE190503T1 (de) 2000-04-15
SA94150156B1 (ar) 2005-05-15
RU94028653A (ru) 1996-09-10
NZ264142A (en) 1996-11-26
CZ182594A3 (en) 1995-02-15

Similar Documents

Publication Publication Date Title
IL110510A (en) Pharmaceutical preparations containing glucosidase and / or amylase inhibitor and lipase inhibitor
US5436272A (en) Treatment of obesity
US5854238A (en) Use of a thienotriazolodiazephine to increase apolipoprotein A-I levels
US5665352A (en) Process for reducing the extent of cryptosporidium diarrhoeas
EP0882450A2 (en) Cholesterol-lowering composition comprising coenzyme Q
US4435449A (en) Treatment of minimal brain dysfunction (MBD)
US5055460A (en) Method for weight loss
US4425363A (en) Treatment of tardive dyskinesia in mammals
US4438138A (en) Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
ERIC et al. Chronic Isospora belli infection treated with co-trimoxazole
EP0629400B1 (en) Idebenone compositions for treating Alzheimer's disease
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
JPH11255656A (ja) 抗アトピー性皮膚炎組成物
US5627152A (en) Method for increasing bodyweight
US5102883A (en) Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
JP2002226369A (ja) グルタミン含有経口組成物
US4501737A (en) Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat myodystrophia
AU770580B2 (en) Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
US4401671A (en) Treatment of giardiasis and trichomoniasis
US4424220A (en) Treatment of giardiasis and trichomoniasis
WO2002026104A2 (en) A combination of appetite controlling agents which create a synergy and produce a satiating result
Koller et al. Four Misdiagnoses of Acute Abdominal Pain in a Young Woman
JPS6232727B2 (zh)
WO1988010115A1 (fr) Medicament anti-nauseeux sans somnolence
CONFIRM GITALIGIN”

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired